<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Sun, 24 May 2026 04:15:28 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/antibody/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[My Version Herbal Drink.  I call it "Jamu"]]></title><description><![CDATA[Hello good morning friends #amazingdrinks. how are you all today? we are already in December. In Indonesia, it means the rainy month. Why is it so? I don't know, maybe because we're used to it always raining]]></description><link>http://direct.ecency.com/hive-189869/@cacasa26/my-version-herbal-drink-i-call-it-jamu</link><guid isPermaLink="true">http://direct.ecency.com/hive-189869/@cacasa26/my-version-herbal-drink-i-call-it-jamu</guid><category><![CDATA[hive-189869]]></category><dc:creator><![CDATA[cacasa26]]></dc:creator><pubDate>Fri, 08 Dec 2023 01:18:27 GMT</pubDate><enclosure url="https://i.ecency.com/DQmRfKjZQwukh73fgZeYP6thHr6V4ff29HQqawrSJqNS6zW/img_0.4132229480783679.jpg" length="0" type="image/jpeg"/></item><item><title><![CDATA[AstraZeneca vaccine may increase risk of serious neurological condition]]></title><description><![CDATA[( 28 May 2022 ) AstraZeneca vaccine may increase risk of serious neurological condition Souce Scientists believe the jab’s Trojan horse delivery system could be causing a rise in Guillain-Barré syndrome]]></description><link>http://direct.ecency.com/hive-148441/@jorgebgt/astrazeneca-vaccine-may-increase-risk</link><guid isPermaLink="true">http://direct.ecency.com/hive-148441/@jorgebgt/astrazeneca-vaccine-may-increase-risk</guid><category><![CDATA[hive-148441]]></category><dc:creator><![CDATA[jorgebgt]]></dc:creator><pubDate>Sun, 29 May 2022 00:43:45 GMT</pubDate><enclosure url="https://i.ecency.com/p/BM7WWisF8H7NxFR8k8CHBJW6UPc5vqoVN1eefwZQB8hrKZNMVQfGcdcrLpA1sGUCPCx1Z1aVJC8uoNTP7a67BBc6B4DHkgyM8VKyq2HLTMuuT6XufxERupKJVaUZQeJFDxzqspxvWbk8WgnR87t1uGeebJUXgdRASi71guo1DmdpQBMJGsP7JafZfDr5JdAFAaTJUmZvMZGQUBvQVjCfsc2npSGahXRXRcDwD4C?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[ SARS-CoV2 antibodies can also be transmitted through the air.]]></title><description><![CDATA[( 2022.04.28. ) Evidence for Aerosol Transfer of SARS-CoV2-specific Humoral Immunity Souce Despite the obvious knowledge that infectious particles can be shared through respiration, whether other constituents]]></description><link>http://direct.ecency.com/hive-148441/@jorgebgt/sars-cov2-antibodies-can-also</link><guid isPermaLink="true">http://direct.ecency.com/hive-148441/@jorgebgt/sars-cov2-antibodies-can-also</guid><category><![CDATA[hive-148441]]></category><dc:creator><![CDATA[jorgebgt]]></dc:creator><pubDate>Tue, 03 May 2022 14:51:36 GMT</pubDate><enclosure url="https://i.ecency.com/p/C3TZR1g81UNaPs7vzNXHueW5ZM76DSHWEY7onmfLxcK2iNpxpb7jHd5Vc182V7WDhytkFPSUUy1hPQbvG7V3XoQroi9V3WgyG4AEgmuxo7r6VC5RukfDznJ?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[My Actifit Report Card: March 29 2022]]></title><description><![CDATA[Antigen antibody complex Meer This report was published via Actifit app (Android | iOS). Check out the original version here on actifit.io 28/03/2022 5401 Daily Activity]]></description><link>http://direct.ecency.com/hive-193552/@aadilmir/actifit-aadilmir-20220329t173232438z</link><guid isPermaLink="true">http://direct.ecency.com/hive-193552/@aadilmir/actifit-aadilmir-20220329t173232438z</guid><category><![CDATA[hive-193552]]></category><dc:creator><![CDATA[aadilmir]]></dc:creator><pubDate>Tue, 29 Mar 2022 17:32:33 GMT</pubDate><enclosure url="https://i.ecency.com/p/ADdPNihJzmPcLkHtjKRVWu2N2uvBRfNLKJYb8XFwPf7BaeSv9QcNwXjtBwLE8jQtRxbCG1nxRzH7KHkJfRKa37LRN?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[On ADE (Antibody Dependent Enhancement).]]></title><description><![CDATA[Prior to the release of data from the Moderna and Pfizer Phase III clinical trials (as well as the large accumulation of data since the vaccines were authorized under the EUA), there was widespread glurge]]></description><link>http://direct.ecency.com/covid/@zafrada/on-ade-antibody-dependent-enhancement</link><guid isPermaLink="true">http://direct.ecency.com/covid/@zafrada/on-ade-antibody-dependent-enhancement</guid><category><![CDATA[covid]]></category><dc:creator><![CDATA[zafrada]]></dc:creator><pubDate>Sun, 12 Sep 2021 03:02:54 GMT</pubDate><enclosure url="https://i.ecency.com/p/4HFqJv9qRjVecs4xkhd5EvhidWEEBnn9tCVDBkBhQpUFvab78MhbU1VvqsDRnXEemPE9uJJL42V1fNVuPTJyPGT95xDFcQeuWYoMoaigGQycwdDFguKvWHe8FoSfmcssuaRoSRc1t4TU7ZZLak8nQPFARmzZ59bQykJ?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Pfizer vaccine antibody responses stronger in those infected with prior covid, also increases resistance to other coronaviruses.]]></title><description><![CDATA[Several studies have shown that those who have been infected with covid tend to have a stronger antibody response to vaccination. This is compared to people who have no prior infection and get the jab.]]></description><link>http://direct.ecency.com/covid/@zafrada/pfizer-vaccine-antibody-responses-stronger-in-those-infected-with-prior-covid-also-increases-resistance-to-other-coronaviruses</link><guid isPermaLink="true">http://direct.ecency.com/covid/@zafrada/pfizer-vaccine-antibody-responses-stronger-in-those-infected-with-prior-covid-also-increases-resistance-to-other-coronaviruses</guid><category><![CDATA[covid]]></category><dc:creator><![CDATA[zafrada]]></dc:creator><pubDate>Thu, 19 Aug 2021 23:24:09 GMT</pubDate><enclosure url="https://i.ecency.com/p/26uUsAjKTsXCDw7zixZR182JbFKvgzJ9YwsFpTVcRaGCmsqhA1unTgpra1Kwf2Avsq5j479aFAAP7nvVuNNiy1fq1zF6idiNvVEM1c126RRB5sSGuPU7oUz8HRTExepHNnxxbKPNzUFTHX4CKBcSwYhmn1WCwMtWnxuuWN?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Threshold of antibodies considered good enough for protection?]]></title><description><![CDATA[This study by Moderna correlates antibody levels in their COVE trial participants on day 57 (counting from the first dose) with vaccine efficacy from day 57 to day 100. This study is similar to a study]]></description><link>http://direct.ecency.com/covid/@zafrada/threshold-of-antibodies-considered-good-enough-for-protection</link><guid isPermaLink="true">http://direct.ecency.com/covid/@zafrada/threshold-of-antibodies-considered-good-enough-for-protection</guid><category><![CDATA[covid]]></category><dc:creator><![CDATA[zafrada]]></dc:creator><pubDate>Thu, 12 Aug 2021 02:37:45 GMT</pubDate><enclosure url="https://i.ecency.com/p/4HFqJv9qRjVecs4xkhd5EvhidWEEBnn9tCVDBkBhQpUFvab78MhbU1VvqsDRnXEemPE9th84UpdtSpNbXWCE5nQmBrQwjw8jNbFBXTB3K44utj3PGj1pvLYN2G6tLN5az7KDcaaFCQELtcG35Q5wL54RwKiuW6Vahsk?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[A study on breakthrough infections in vaccinated healthcare workers.]]></title><description><![CDATA[A large medical center in Israel had previously done a study in which they took blood samples from employees to measure antibody levels at intervals after vaccination with Pfizer. Subsequently, 39 fully]]></description><link>http://direct.ecency.com/covid/@zafrada/a-study-on-breakthrough-infections-in-vaccinated-healthcare-workers</link><guid isPermaLink="true">http://direct.ecency.com/covid/@zafrada/a-study-on-breakthrough-infections-in-vaccinated-healthcare-workers</guid><category><![CDATA[covid]]></category><dc:creator><![CDATA[zafrada]]></dc:creator><pubDate>Thu, 29 Jul 2021 00:57:09 GMT</pubDate><enclosure url="https://i.ecency.com/p/26uUsAjKTsXCDw7zixZR182JbFKvgzJ9YwsFpTVcRaGCmsqhA1unTgpra1Kwf2Avsq5j46xNnNza5P3cBMCYFne2BWADcmDeLNn6QfxpPc8r7o4uRqz9cMep1W6SBcdAzHKa5FuGV9xw7JoXXGobjmT3X87DYqPmDsnZ26?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[J&J vaccine trial shows excellent efficacy against Delta variant. ]]></title><description><![CDATA[Today J&J released an 8-month update study in a small subset of trial participants (8 people), including information on the delta variant. They chose an older subset ranging in age from 47-91, in order]]></description><link>http://direct.ecency.com/covid/@zafrada/jandj-vaccine-trial-shows-excellent-efficacy-against-delta-variant</link><guid isPermaLink="true">http://direct.ecency.com/covid/@zafrada/jandj-vaccine-trial-shows-excellent-efficacy-against-delta-variant</guid><category><![CDATA[covid]]></category><dc:creator><![CDATA[zafrada]]></dc:creator><pubDate>Sat, 03 Jul 2021 00:39:15 GMT</pubDate><enclosure url="https://i.ecency.com/p/26uUsAjKTsXCDw7zixZR182JbFKvgzJ9YwsFpTVcRaGCmsqhA1unTgpra1Kwf2Avsq5j4799CLPmpEtbDuEeh7KVtnLiA8FFioH8D7EbP96Zv45YzFmVuRCMHfDE6xtMrjPvHSFFfd8mJ9NAn9dv8P8KoZYE946ANWjhj4?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Booster trials.]]></title><description><![CDATA[It was supposed to start this coming week, but Pfizer is shifting it to the following week in order to get their paperwork in order. As I mentioned before, the design of the study is to give 10,000 people]]></description><link>http://direct.ecency.com/covid/@zafrada/booster-trials</link><guid isPermaLink="true">http://direct.ecency.com/covid/@zafrada/booster-trials</guid><category><![CDATA[covid]]></category><dc:creator><![CDATA[zafrada]]></dc:creator><pubDate>Mon, 28 Jun 2021 00:01:57 GMT</pubDate><enclosure url="https://i.ecency.com/p/26uUsAjKTsXCDw7zixZR182JbFKvgzJ9YwsFpTVcRaGCmsqhA1unTgpra1Kwf2Avsq5j476ohnETcqp6SsTGy91qwVWzRZbhhUN4HMrs1o94sKqUgGS3wJjfE4uRLHt9Y6YVDis4UCkYt4HJciEFKbjbrtXUZWho8yBMCi?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[What antibody levels are protective - How much decay with AZ?]]></title><description><![CDATA[I have been waiting for a long time for the companies running the vaccine trials to release data on what antibody level is protective. They took blood samples after the second shot, and have been monitoring]]></description><link>http://direct.ecency.com/covid/@zafrada/what-antibody-levels-are-protective-how-much-decay-with-az</link><guid isPermaLink="true">http://direct.ecency.com/covid/@zafrada/what-antibody-levels-are-protective-how-much-decay-with-az</guid><category><![CDATA[covid]]></category><dc:creator><![CDATA[zafrada]]></dc:creator><pubDate>Fri, 25 Jun 2021 01:38:45 GMT</pubDate><enclosure url="https://i.ecency.com/p/26uUsAjKTsXCDw7zixZR182JbFKvgzJ9YwsFpTVcRaGCmsqhA1unTgpra1Kwf2Avsq5j477WnMmMCYK8h1P2QbVRZKgGCp5HD1P9qw1Egjqwd6AVubV6NgJFuBLiHJvgrQyAccmXm7zsWaZdtf78Cr4uDccXdobRSxZXEn?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Breakthrough infections with other viruses. ]]></title><description><![CDATA[I've been doing some reading about breakthrough infections with vaccines to other viruses. The ones that I found the most data on were hepatitis B and E. The Hep B virus is transmitted mostly by contact]]></description><link>http://direct.ecency.com/hepatitis/@zafrada/breakthrough-infections-with-other-viruses</link><guid isPermaLink="true">http://direct.ecency.com/hepatitis/@zafrada/breakthrough-infections-with-other-viruses</guid><category><![CDATA[hepatitis]]></category><dc:creator><![CDATA[zafrada]]></dc:creator><pubDate>Sat, 19 Jun 2021 20:39:18 GMT</pubDate><enclosure url="https://i.ecency.com/p/26uUsAjKTsXCDw7zixZR182JbFKvgzJ9YwsFpTVcRaGCmsqhA1unTgpra1Kwf2Avsq5j4799CLPok6dbxGG2dEF8MHMP5BLFEKk1Ruj8GLvpW59fUTsSo5UPwhYWTyrsnK6ULDTxipPxSGSsd5EXjb4RTPgFg2NULb53dQ?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[New study shows prior infections yield no reinfections - Is there a humanitarian case to give excess vaccines to regions that need it more?]]></title><description><![CDATA[Sometimes different groups of scientists do similar experiments and come up with different results and different conclusions. For people who have an authoritarian view of science, this can be distressing,]]></description><link>http://direct.ecency.com/covid/@zafrada/new-study-shows-prior-infections-yield-no-reinfections-is-there-a-humanitarian-case-to-give-excess-vaccines-to-regions-that-need</link><guid isPermaLink="true">http://direct.ecency.com/covid/@zafrada/new-study-shows-prior-infections-yield-no-reinfections-is-there-a-humanitarian-case-to-give-excess-vaccines-to-regions-that-need</guid><category><![CDATA[covid]]></category><dc:creator><![CDATA[zafrada]]></dc:creator><pubDate>Mon, 07 Jun 2021 01:31:36 GMT</pubDate><enclosure url="https://i.ecency.com/p/26uUsAjKTsXCDw7zixZR182JbFKvgzJ9YwsFpTVcRaGCmsqhA1unTgpra1Kwf2Avsq5j478hRwegBRqWeGaEFjciGZzxx6WNo5uE4FCXPv8t46afqjAuRaZ2fFGk9k3wtrHwHa4Gr6MbQavR8MTn8D9Dm59BpggdDVxBtS?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Establishing an international standard for measuring antibody activity.]]></title><description><![CDATA[This one is going to take some explaining, but it is relevant for the search to figure out what level of antibodies is protective. The study measured antibody levels over time in dental health care workers]]></description><link>http://direct.ecency.com/covid/@zafrada/establishing-an-international-standard-for-measuring-antibody-activity</link><guid isPermaLink="true">http://direct.ecency.com/covid/@zafrada/establishing-an-international-standard-for-measuring-antibody-activity</guid><category><![CDATA[covid]]></category><dc:creator><![CDATA[zafrada]]></dc:creator><pubDate>Sun, 06 Jun 2021 01:28:54 GMT</pubDate><enclosure url="https://i.ecency.com/p/26uUsAjKTsXCDw7zixZR182JbFKvgzJ9YwsFpTVcRaGCmsqhA1unTgpra1Kwf2Avsq5j47813pEEq3YSBG9kVevgSm5LUwDDkkwkVhsL6d13JxZYxCSaWNR1sDHK3DJSNWDayeDYvT7MiFVmtjyNjHt26aQ73WxYMghKie?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Gauging the likelihood of reinfection - A study in UK.]]></title><description><![CDATA[The UK is monitoring reinfections in a group of 9813 health care workers with prior infection. In order to count as a potential reinfection, they must have a second positive PCR test more than 90 days]]></description><link>http://direct.ecency.com/covid/@zafrada/gauging-the-likelihood-of-reinfection-a-study-in-uk</link><guid isPermaLink="true">http://direct.ecency.com/covid/@zafrada/gauging-the-likelihood-of-reinfection-a-study-in-uk</guid><category><![CDATA[covid]]></category><dc:creator><![CDATA[zafrada]]></dc:creator><pubDate>Sat, 05 Jun 2021 03:02:45 GMT</pubDate><enclosure url="https://i.ecency.com/p/26uUsAjKTsXCDw7zixZR182JbFKvgzJ9YwsFpTVcRaGCmsqhA1unTgpra1Kwf2Avsq5j478hRFLXAcaUyQLYhUkEVdAYqVoyp9JuVzTcjmqdfQf1xKYa5G2ZDiphDkyWyzFdUcyCzsKpTVayTaKQewPHhxi5zerwz94YLe?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans.]]></title><description><![CDATA[A long-lived antibody response requires that B-cells become activated in lymph nodes, develop first into plasmablasts, and then finally into plasma cells, which live in the bone marrow rather than the]]></description><link>http://direct.ecency.com/covid/@zafrada/sars-cov-2-infection-induces-long-lived-bone-marrow-plasma-cells-in-humans</link><guid isPermaLink="true">http://direct.ecency.com/covid/@zafrada/sars-cov-2-infection-induces-long-lived-bone-marrow-plasma-cells-in-humans</guid><category><![CDATA[covid]]></category><dc:creator><![CDATA[zafrada]]></dc:creator><pubDate>Sat, 29 May 2021 01:11:39 GMT</pubDate><enclosure url="https://i.ecency.com/p/4HFqJv9qRjVecs4xkhd5EvhidWEEBnn9tCVDBkBhQpUFvab78MhbU1VvqsDRnXEemPE9uFXg8yhz3JJvNA6mBNFzcRSjHwmgjopSHn7dSVZ4YrKw92FsHcdVQJp7a915WMi2rXMbi6XTMnAzJxPGLvarfqCxPQPSPfC?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[New study shows prior infection leads to much better antibody response with vaccines. ]]></title><description><![CDATA[This study is similar to many others that have showed that people with prior infection have a much better antibody response to vaccination than do those with no prior exposure to the virus. The thing that]]></description><link>http://direct.ecency.com/covid/@zafrada/new-study-shows-prior-infection-leads-to-much-better-antibody-response-with-vaccines</link><guid isPermaLink="true">http://direct.ecency.com/covid/@zafrada/new-study-shows-prior-infection-leads-to-much-better-antibody-response-with-vaccines</guid><category><![CDATA[covid]]></category><dc:creator><![CDATA[zafrada]]></dc:creator><pubDate>Fri, 28 May 2021 03:11:15 GMT</pubDate><enclosure url="https://i.ecency.com/p/26uUsAjKTsXCDw7zixZR182JbFKvgzJ9YwsFpTVcRaGCmsqhA1unTgpra1Kwf2Avsq5j47XTfnHKZTTNeySMKfkFMC8BUFpEJn6SeE63W5M9CW28Zu1DSY7Tc9YbrgbAkXLZUAWQquVkkwGDFECKixgJmME8LVW4JNBVSE?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Why is there so much variation between individuals in the antibody response to vaccination?]]></title><description><![CDATA[In order to get high levels of long-lasting antibodies, you need a good CD4+ T-cell response. These are also called helper T-cells and are the cells that are killed by HIV. When their levels dip too low,]]></description><link>http://direct.ecency.com/covid/@zafrada/why-is-there-so-much-variation-between-individuals-in-the-antibody-response-to-vaccination</link><guid isPermaLink="true">http://direct.ecency.com/covid/@zafrada/why-is-there-so-much-variation-between-individuals-in-the-antibody-response-to-vaccination</guid><category><![CDATA[covid]]></category><dc:creator><![CDATA[zafrada]]></dc:creator><pubDate>Thu, 27 May 2021 04:10:12 GMT</pubDate><enclosure url="https://i.ecency.com/p/26uUsAjKTsXCDw7zixZR182JbFKvgzJ9YwsFpTVcRaGCmsqhA1unTgpra1Kwf2Avsq5j47hX2oKNtAMzBJ3nWELXThgPmKJu34CN7cpPNSMzYfotpCuEFH7iDhJzySSi85E7DbdcfvwkJfii9vESv2DKxpQFazwaMZH3XL?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Some anti-body results from my participation in vaccine trial.]]></title><description><![CDATA[One of the unexpected bonuses of participating in a vaccine trial was finding an online community of like-minded fellow trial participants. As you might imagine, science nerds are over-represented in these]]></description><link>http://direct.ecency.com/covid/@zafrada/some-anti-body-results-from-my-participation-in-vaccine-trial</link><guid isPermaLink="true">http://direct.ecency.com/covid/@zafrada/some-anti-body-results-from-my-participation-in-vaccine-trial</guid><category><![CDATA[covid]]></category><dc:creator><![CDATA[zafrada]]></dc:creator><pubDate>Sun, 23 May 2021 22:19:39 GMT</pubDate><enclosure url="https://i.ecency.com/p/26uUsAjKTsXCDw7zixZR182JbFKvgzJ9YwsFpTVcRaGCmsqhA1unTgpra1Kwf2Avsq5j476oiSxcbYpGtMqGvrC31b3RhF8LCp45F4GMwC8skzHwe7zoguGHyCY4gFDLTumkSY4z3WZ2eN959WmSwLfqBP1tzGK8r5TiTG?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Examining three methods for antibody-based immunity. ]]></title><description><![CDATA[Link to study: This is a really interesting study on an aspect of immunity to SARS CoV-2 that to my knowledge has not been examined anywhere else. While we have seen many studies on virus neutralization]]></description><link>http://direct.ecency.com/covid/@zafrada/examining-three-methods-for-antibody-based-immunity</link><guid isPermaLink="true">http://direct.ecency.com/covid/@zafrada/examining-three-methods-for-antibody-based-immunity</guid><category><![CDATA[covid]]></category><dc:creator><![CDATA[zafrada]]></dc:creator><pubDate>Wed, 19 May 2021 01:24:03 GMT</pubDate><enclosure url="https://i.ecency.com/p/k75bsZMwYNu2L3iBMXq5y7xeiy1isFJsZxnMZSXuXEsxe4ee1cUkGyQ5GufEwRqtHodXj6V23AWQDPNMM86VroB3KtdyjigdcY8LVYM6a32g38NXPLdZBpHZ8Pe2HV8m1JqqB49j38Nxsxnk6pbu643wYn1pF6qAN?format=match&amp;mode=fit" length="0" type="false"/></item></channel></rss>